Ignite Creation Date:
2024-05-05 @ 9:08 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00810017
Status:
TERMINATED
Last Update Posted:
2022-05-19
First Post:
2008-12-16
Brief Title:
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Sponsor:
Organization:
Medstar Health Research Institute